Tafenoquine for Plasmodium vivax malaria
In this blog the authors discuss a new drug called tafenoquine, approved by the United States Food and Drug Administration in 2018 to prevent all… Read more »
In this blog the authors discuss a new drug called tafenoquine, approved by the United States Food and Drug Administration in 2018 to prevent all… Read more »
In their BMC Medicine article, Laura Nabarro and colleagues highlight the issues with the lesser-known Plasmodium ovale malaria species, arguing that… Read more »
Malaria is the leading cause of parasitic disease, killing nearly half a million people per year, most of whom are African… Read more »
More than 200 million people are treated for malaria each year, small children are the worst affected across sub-Saharan Africa.… Read more »
From 1-5 July 2018, Melbourne hosted the inaugural Malaria World Congress, welcoming delegates from 66 countries. BMC Medicine… Read more »
In a recent article in the Journal of the European Optical Society-Rapid Publications, researchers use devices based on a… Read more »
Prof Youyou Tu has been awarded the Nobel Prize “for her discoveries concerning a novel therapy against Malaria”. Here, we ask… Read more »
Malaria intervention coverage has rapidly increased across regions in Uganda, according to a new study published in BMC Medicine.… Read more »
Last week, BMC Medicine attended the American Society for Tropical Medicine and Hygiene conference to hear about the latest… Read more »
Today in BMC Medicine, experts working in malaria research and control from across the globe discuss different ways in which… Read more »